Presentation is loading. Please wait.

Presentation is loading. Please wait.

Malignant Meningioma: rarity to creativity

Similar presentations


Presentation on theme: "Malignant Meningioma: rarity to creativity"— Presentation transcript:

1 Malignant Meningioma: rarity to creativity
MGH Neurosurgery Grand Rounds August 23, 2012 Leonardo Aliaga University of Chicago

2 Complex history of multiple recurrent meningiomas
JD, 53y/o RHM Complex history of multiple recurrent meningiomas 2008

3 2008 – initial resection at Umass Path – atypical meningioma (II) 2010 April – Proton beam therapy 2011 March – 2nd resection 4 meningiomas removed Radioactive iodine seeds placed Path – rhabdoid malignant meningioma (III) 2011 March, preop

4 Asdasd 2011 July October

5 Asdasd 2011 July October

6 2011 October February June 3rd resection

7 2012 June

8 August 2012, 4th resection Worsening left sided weakness Worsening eye pain, proptosis

9 August 2012, 4th resection Planned subtotal resection, sparing of eye
Right frontal craniotomy - resection of 2 frontal parasagittal meningiomas Right orbitozygomatic osteotomy - resection of orbital sphenoid wing recurrence Planned subtotal resection, sparing of eye Exploration of infratemporal fossa

10 August 2012, 4th resection Planned subtotal resection, sparing of eye
Right frontal craniotomy - resection of 2 frontal parasagittal meningiomas Right orbitozygomatic osteotomy - resection of orbital sphenoid wing recurrence Planned subtotal resection, sparing of eye Exploration of infratemporal fossa Plastic surgery – cranioplasty and scalp flap reconstruction

11 Post-op course

12 Post-op course Complicated by low hematocrit, tachycardia, confusion and delerium, downtrending Na Transfused, PE protocol CT negative, Na normalized Discharged on POD 8, LUE 3/5, LLE wiggled toes

13 What does the future hold Mr. JD?

14 Malignant Meningioma Meningiomas – 30% of CNS neoplasm
Grade III – malignant meningioma, 1-3% 2007 WHO Criteria Papillary, rhabdoid and anaplastic histological subtypes 20 or more mitoses per HPF and/or malignant characteristics resembling carcinoma, sarcoma, or melanoma

15 Recurrence, Resection, Radiation

16 Recurrence, Resection, Radiation

17 Recurrence, Resection, Radiation

18 Recurrence, Resection, Radiation
Marked survival benefit for 37 pts undergoing second resection for recurrence

19 Recurrence, Resection, Radiation
34 pts,undergoing primary operation pts, undergoing second operation Minor survival benefit with subtotal resection vs. gross-total resection

20 Recurrence, Resection, Radiation

21 Recurrence, Resection, Radiation
Radiation for recurrence 45 pts undergoing resection for recurrence 26 underwent at least 1 treatment of focal radiotherapy SRS Iodine-125 brachytherapy No difference in survival with focal radiotherapy after resection

22 Creativity and the future

23 Thank you MGH Department of Neurosurgery Harvard Medical School
University of Chicago


Download ppt "Malignant Meningioma: rarity to creativity"

Similar presentations


Ads by Google